Trial Outcomes & Findings for Portion Control Treatment for Obesity (NCT NCT01451554)

NCT ID: NCT01451554

Last Updated: 2011-11-28

Results Overview

Weight change as a percentage of baseline at post 6 months.

Recruitment status

COMPLETED

Study phase

PHASE2/PHASE3

Target enrollment

65 participants

Primary outcome timeframe

6 months

Results posted on

2011-11-28

Participant Flow

Patients were referred to the study by their primary health care provider. Recruitment began on January 14, 2009 and ended on May 21, 2010.

Participant milestones

Participant milestones
Measure
Portion Control Intervention
Individuals will be given a portion control plate and dietary counseling
Usual Care
Provided with self-help booklets on diet and exercise.
Overall Study
STARTED
33
32
Overall Study
COMPLETED
19
23
Overall Study
NOT COMPLETED
14
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Portion Control Intervention
Individuals will be given a portion control plate and dietary counseling
Usual Care
Provided with self-help booklets on diet and exercise.
Overall Study
Withdrawal by Subject
14
9

Baseline Characteristics

Portion Control Treatment for Obesity

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Portion Control Intervention
n=33 Participants
Individuals will be given a portion control plate and dietary counseling
Usual Care
n=32 Participants
Provided with self-help booklets on diet and exercise.
Total
n=65 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
n=5 Participants
24 Participants
n=7 Participants
52 Participants
n=5 Participants
Age, Categorical
>=65 years
5 Participants
n=5 Participants
8 Participants
n=7 Participants
13 Participants
n=5 Participants
Age Continuous
55.4 years
STANDARD_DEVIATION 9.4 • n=5 Participants
56.3 years
STANDARD_DEVIATION 10.7 • n=7 Participants
55.9 years
STANDARD_DEVIATION 10.0 • n=5 Participants
Sex: Female, Male
Female
20 Participants
n=5 Participants
20 Participants
n=7 Participants
40 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
12 Participants
n=7 Participants
25 Participants
n=5 Participants
Baseline Weight
97.6 Kg
STANDARD_DEVIATION 12.8 • n=5 Participants
98.8 Kg
STANDARD_DEVIATION 12.5 • n=7 Participants
98.2 Kg
STANDARD_DEVIATION 12.6 • n=5 Participants

PRIMARY outcome

Timeframe: 6 months

Population: Intent to treat population includes all randomzied subjects. Missing data were imputed using the last observation carried forward.

Weight change as a percentage of baseline at post 6 months.

Outcome measures

Outcome measures
Measure
Portion Control Intervention
n=33 Participants
Individuals will be given a portion control plate and dietary counseling
Usual Care
n=32 Participants
Provided with self-help booklets on diet and exercise.
Weight Change at 6 Months
-1.2 percentage
Standard Deviation 3.1
-0.4 percentage
Standard Deviation 3.2

SECONDARY outcome

Timeframe: 3 months

Population: Intent to treat population includes all randomzied subjects. Missing data were imputed using the last observation carried forward.

Percentage change in weight at 3 months post study baseline

Outcome measures

Outcome measures
Measure
Portion Control Intervention
n=33 Participants
Individuals will be given a portion control plate and dietary counseling
Usual Care
n=32 Participants
Provided with self-help booklets on diet and exercise.
Weight Change at 3 Months
-1.7 percentage
Standard Deviation 3.3
-0.4 percentage
Standard Deviation 1.9

Adverse Events

Portion Control Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jon O. Ebbert, MD

Mayo Clinic

Phone: 507-255-3965

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place